Baidu
map

BMC Med:男人身高愈高,死于前列腺癌的风险也愈高

2017-10-07 佚名 Technews 科技新报

身高是许多女性选择男友的重要条件之一,据说 178 公分是多数女性心中男友的理想身高。个子高的男人给人一种安全感,站在他身边有一种小鸟依人的幸福感。个子高当然也有缺点,例如看电影座位太挤、买衣服选择较少等。英国最近的研究更显示,高个子的男性罹患“恶性”前列腺癌而死亡的机率较高。

身高是许多女性选择男友的重要条件之一,据说 178 公分是多数女性心中男友的理想身高。个子高的男人给人一种安全感,站在他身边有一种小鸟依人的幸福感。个子高当然也有缺点,例如看电影座位太挤、买衣服选择较少等。英国最近的研究更显示,高个子的男性罹患“恶性”前列腺癌而死亡的机率较高。

前列腺癌是欧洲男性最常罹患的癌症,也是全球男性癌症发生率第二高。年龄是前列腺癌最高的危险因子,不分人种,70 岁以上男性约有一半会产生前列腺癌,此外饮食习惯、遗传基因等也会影响前列腺癌发生。

先前已有一些研究试图厘清男性的身材与罹患前列腺癌之间的关系,初步指出身高较高者罹患此癌的风险较高。由于这些研究调查的人数较少,因此无法详细区分身高与不同期别癌症及因癌症死亡间的关系。

本次由牛津大学(University of Oxford)公共卫生系的 Aurora Perez-Cornago 教授领导的研究,总共分析了欧洲 8 个国家 15 万名男性资料,其中包含 7,024 例前列腺癌病例。研究结果显示,高个子男人和肥胖男性面临较大的前列腺癌风险,他们死于前列腺癌的风险更高。该发已刊登于今年 7 月的《BMC 医学期刊》。

当研究团队初步分析身高与前列腺癌发生机率关联性时,并没有发现任何相关性,身材高矮并没有明显的差别。当他们将前列腺癌仔细分类后则赫然发现身高愈高者,罹患恶性前列腺癌的风险明显上升了,身高每增加 10 公分,罹患恶性前列腺癌的风险上升 21%,死于癌症的风险也增加 17%。

研究人员表示:“本次研究结果突显身高对晚期前列腺癌风险因素的重要性。然而身高无法改变,我们只能建议身高较高的男性更应规律生活、健康饮食(注),并定期体检,以减少前列腺癌趁隙坐大危害身体健康的机会。后续,我们将进一步探究造成此影响的因素(如体内荷尔蒙浓度不同),并提出更多研究证据。”

其实有多项欧洲研究都指出矮个子寿命较长,芬兰的滑冰选手身高平均比篮球队员矮了 12 英寸,寿命却多了 7 年;此外,欧洲平均身高愈矮的国家,百岁人瑞的比例也愈高。夏威夷大学的研究发现,157 公分以下的矮个男性,罹患各种癌症的机率都较低,寿命也较长。

每个人的身高如何,遗传基因占一半以上的决定因素,以目前的医学科技还无法改变。然而无论高矮都有各自的优缺点,因此爱惜上天赐与我们的身体并发挥最大的优点,是我们每个人都应学习的。

注:一般建议多食用蔬菜,减少动物性食物可减少前列腺癌发生。一般而言,食用多量动物性(饱合性)脂肪、肉类、牛奶及奶制品,体内雄性素浓度较素食者高,罹患前列腺癌的机会也较高。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1974770, encodeId=5e3319e4770b9, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 16 11:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608095, encodeId=92c8160809532, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 09 00:24:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251407, encodeId=2efb25140e86, content=学习了.涨知识啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Sun Oct 08 22:33:19 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251121, encodeId=034925112135, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Oct 07 14:58:15 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251084, encodeId=f5b2251084a4, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Oct 07 11:30:24 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251076, encodeId=f4c12510e686, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Oct 07 11:11:41 CST 2017, time=2017-10-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1974770, encodeId=5e3319e4770b9, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 16 11:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608095, encodeId=92c8160809532, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 09 00:24:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251407, encodeId=2efb25140e86, content=学习了.涨知识啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Sun Oct 08 22:33:19 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251121, encodeId=034925112135, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Oct 07 14:58:15 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251084, encodeId=f5b2251084a4, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Oct 07 11:30:24 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251076, encodeId=f4c12510e686, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Oct 07 11:11:41 CST 2017, time=2017-10-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1974770, encodeId=5e3319e4770b9, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 16 11:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608095, encodeId=92c8160809532, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 09 00:24:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251407, encodeId=2efb25140e86, content=学习了.涨知识啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Sun Oct 08 22:33:19 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251121, encodeId=034925112135, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Oct 07 14:58:15 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251084, encodeId=f5b2251084a4, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Oct 07 11:30:24 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251076, encodeId=f4c12510e686, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Oct 07 11:11:41 CST 2017, time=2017-10-07, status=1, ipAttribution=)]
    2017-10-08 15938038573红旗飘飘

    学习了.涨知识啦!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1974770, encodeId=5e3319e4770b9, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 16 11:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608095, encodeId=92c8160809532, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 09 00:24:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251407, encodeId=2efb25140e86, content=学习了.涨知识啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Sun Oct 08 22:33:19 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251121, encodeId=034925112135, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Oct 07 14:58:15 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251084, encodeId=f5b2251084a4, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Oct 07 11:30:24 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251076, encodeId=f4c12510e686, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Oct 07 11:11:41 CST 2017, time=2017-10-07, status=1, ipAttribution=)]
    2017-10-07 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1974770, encodeId=5e3319e4770b9, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 16 11:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608095, encodeId=92c8160809532, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 09 00:24:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251407, encodeId=2efb25140e86, content=学习了.涨知识啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Sun Oct 08 22:33:19 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251121, encodeId=034925112135, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Oct 07 14:58:15 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251084, encodeId=f5b2251084a4, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Oct 07 11:30:24 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251076, encodeId=f4c12510e686, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Oct 07 11:11:41 CST 2017, time=2017-10-07, status=1, ipAttribution=)]
    2017-10-07 1e0f8808m18(暂无匿称)

    好文章.学习了.

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1974770, encodeId=5e3319e4770b9, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 16 11:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608095, encodeId=92c8160809532, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 09 00:24:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251407, encodeId=2efb25140e86, content=学习了.涨知识啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Sun Oct 08 22:33:19 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251121, encodeId=034925112135, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Oct 07 14:58:15 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251084, encodeId=f5b2251084a4, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sat Oct 07 11:30:24 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251076, encodeId=f4c12510e686, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Oct 07 11:11:41 CST 2017, time=2017-10-07, status=1, ipAttribution=)]
    2017-10-07 Y—xianghai

    学习了新知识

    0

相关资讯

小心,四种药物让孩子长不高!

最近,一些药物在使用过程中逐渐被发现可导致婴幼儿生长发育障碍,给儿童带来极大的伤害。现为大家揭开影响婴幼儿生长发育药物杀手的面目。1、肾上腺皮质激素(如甲泼尼龙、地塞米松等)我们都知道婴幼儿极少用到激素类药物,为何肾上腺皮质激素会影响婴幼儿生长发育?这种药物对婴幼儿的影响主要是通过乳汁,如果哺乳期妇女长期使用肾上腺皮质激素治疗,激素就可以从乳汁中排出。婴幼儿吸入后可抑制垂体分泌生长激素,肾上腺皮质

Int J Cancer:乳腺癌的独立危险因素——青春期发育的年龄和成人身高

成人身高与乳腺癌风险呈正相关。既往的研究发现,青春期的年龄——月经初潮时的年龄和到达身高(停止长高)时的年龄——也可能影响乳腺癌风险。来自美国的研究人员在前瞻性黑人妇女健康研究中的55687名非洲裔美国女性中,探讨了成人身高、到达身高时的年龄和初潮年龄与侵袭性乳腺癌发生率的关系。病程超过20年的1826例浸润性乳腺癌(1015例为雌激素受体[ER]阳性;542例为ER阴性)被纳入该研究。交互调整三

JAMA Pediatr:预防骨折——青少年身高与骨密度增长速度的差异研究

儿童时期,身高的增长大大超过了骨矿物质含量的增加导致儿童骨折风险增加。在儿童期身高与成年期相差较少但骨密度含量却较低,因此应强化儿童以及青少年期的骨密度管理。

又高又胖,前列腺癌的发生风险升高!

近期,来自英国牛津大学的一项研究探究了身高、肥胖和前列腺癌等级之间的关系。研究数据来自欧洲癌症和营养的前瞻性调查,包括141896名来自丹麦、意大利、德国、希腊、荷兰、西班牙、瑞典、和英国的参与者,平均年龄是52岁。在这些参与者中,共有7024名前列腺癌患者,其中726名患者为高级别前列腺癌患者,1388名为晚期前列腺癌患者,此外,还有934名前列腺癌患者死亡。对数据进行分析后,研究小组得出结论,

Am J Clin Nutr:注意了!喝非牛乳饮料的儿童比喝牛奶的矮

身高是儿童全面营养状况、健康和发展的重要指标。牛奶是膳食蛋白质和脂肪-2等基本营养物质的重要来源,能促进儿童长高。然而,近些年,一些家长倾向于选择非牛乳饮料代替牛奶。2017年8月,发表在《Am J Clin Nutr》的一项由加拿大科学家进行的中介效应分析,考察了儿童消耗牛奶和非牛乳饮料对身高的影响。

Pediatrics:预防贫困地区幼儿因营养不良导致的发育迟缓,每天一个鸡蛋的作用得到肯定

根据在厄瓜多尔进行的一个为期六个月的研究显示,每天一个鸡蛋可以帮助营养不良的儿童成长到健康的身高。无论是软蒸、硬煮、炒或搅进其他食物,鸡蛋都能促进婴幼儿的发育。儿科杂志上的研究者说,人生第一个两年的营养情况对日后的生长发育至关重要,该时期任何发育障碍带来的影响都是不可逆的,而这是一个预防发育迟缓的较为廉价的方式。

Baidu
map
Baidu
map
Baidu
map